The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphoma

Abstract Purpose The multicentre response-adapted paediatric Hodgkin lymphoma trial GPOH-HD95 (1995–2001, 925 patients) was followed by the ‘HD-Interval’ period (2001–2002, 203 patients). During this period, treatment was recommended according to GPOH-HD95 protocol with only minor changes. Central r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) 2014-01, Vol.50 (2), p.425-433
Hauptverfasser:	Lüders, Heike, Rühl, Ursula, Marciniak, Heinz, Haerting, Johannes, Claviez, Alexander, Mann, Georg, Schellong, Günther, Wickmann, Lutz, Dörffel, Wolfgang
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Central review Chemoradiotherapy - methods Child Clinical Trials Data Monitoring Committees - standards Disease-Free Survival Female Hematology, Oncology and Palliative Medicine Hodgkin Disease - diagnosis Hodgkin Disease - drug therapy Hodgkin Disease - radiotherapy Hodgkin lymphoma Humans Magnetic Resonance Imaging Male Medical sciences Outcome Assessment (Health Care) Paediatric Pharmacology. Drug treatments Practice Guidelines as Topic - standards Radiotherapy Dosage Reference centre Remission Induction Research Design - standards Tomography, X-Ray Computed Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!